| Financial Year |
March 31 2023 |
| Monetary Funds |
345,204,806.74 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
149,944,420.39 |
| Advances to Suppliers |
45,545,490.29 |
| Other Receivables |
33,648,327.36 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
884,240,100.45 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
12,195,783.22 |
| Total Current Assets |
1,964,491,919.80 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
374,523,620.70 |
| Fixed Assetes |
1,930,788,678.80 |
| Under-construction Projects |
466,758,380.04 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
341,284,967.80 |
| R&D expenses |
-- |
| Goodwill |
737,714.75 |
| Long-Term Deferred and Prepaid Expenses |
50,823,538.90 |
| Deferred Income Tax Assets |
185,481,958.80 |
| Other Non-Current Assets |
98,271,147.34 |
| Sub-Total of Non-Current Assets |
3,451,747,795.00 |
| Total Assets |
5,416,239,714.80 |
| Short-Term Loans |
525,920,550.24 |
| Trading Financial liabilities |
-- |
| Notes Payable |
23,800,000.00 |
| Accounts Payable |
433,721,525.48 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
14,067,764.10 |
| Taxes Payable |
71,213,644.44 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
304,145,576.59 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
17,672,585.08 |
| Other Current Liabilities |
193,091,839.07 |
| Sub-Total of Current Liabilities |
1,629,560,374.67 |
| Long-term Loans |
1,211,639,943.06 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
32,358,336.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
89,783,236.45 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,353,538,071.98 |
| Total Liabilities |
2,983,098,446.65 |
| Paid-In Capital(Or Share Stock) |
662,572,861.00 |
| Capital Surplus |
145,153,689.62 |
| Surplus Reserve |
180,718,411.53 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
988,773,049.24 |
| Minority Stockholder's Interest |
435,728,842.96 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,997,412,425.19 |
| Owner's Equity（Stockholder's Equity） |
2,433,141,268.15 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,416,239,714.80 |
